Merck KGaA and Pfizer PD-L1 inhibitor Bavencio has missed the mark in its second ovarian cancer tria
Read More
Antibiotics are overused in up to 50 percent of patients undergoing common urological procedures, su
Read More
US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiom
Read More
Walgreens and Verily, a company owned by Alphabet, Inc., will partner to improve chronic disease man
Read More
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently rece
Read More
L7 International has published the long-anticipated FHIR Release 4 (R4), allowing healthcare organiz
Read More
UnitedHealthcare has sent letters to members, advising them that the company has yet to extend its c
Read More